Answers are grounded in this paper and cite their sources.
during the development of DN in diabetic mice and that small molecules targeting YY1 may serve as promising therapies for treating DN.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: